Evidence map›Paper›PMID 39402727›Full record

ArticleThe journal of vascular access2025

Treatment with a self-expanding endoprosthesis in patients with stenosis or occlusion at the arteriovenous graft: 6-Month outcomes of a post-marketing surveillance study.

Hiroaki Haruguchi, Mizuya Fukasawa, Kiyoshi Ikeda, Kotaro Suemitsu, Takashi Sato, Masahito Miyamoto, Masaaki Murakami, Junichi Nakamura, Tomonaga Noguchi, Daihiko Eguchi and 2 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of vascular access, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Catch Up with the Latest Trend in Vascular Access Intervention.Interventional radiology (Higashimatsuyama-shi (Japan) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hiroaki HaruguchiHaruguchi Vascular Access Clinic, Tokyo, Japan.ORCID 0000-0001-5713-987X
Mizuya FukasawaKanoiwa General Hospital, Yamanashi, Japan.
Kiyoshi IkedaIkeda Vascular Access, Dialysis and Internal Medicine Clinic, Fukuoka, Japan.
Kotaro SuemitsuKansai Rosai Hospital, Hyogo, Japan.ORCID 0000-0002-4251-5315
Takashi SatoKaikoukai Central Clinic, Aichi, Japan.
Masahito MiyamotoYokohama Daiichi Hospital, Kanagawa, Japan.
Masaaki MurakamiShizuoka General Hospital, Shizuoka, Japan.ORCID 0000-0002-2294-194X
Junichi NakamuraTemma Nakamura Clinic, Osaka, Japan.
Tomonaga NoguchiKichijoji Asahi Hospital, Tokyo, Japan.
Daihiko EguchiFukuoka City Hospital, Fukuoka, Japan.
Taro KamimuraMatsuyama Red Cross Hospital, Ehime, Japan.
Kiyoshi AikawaNagoya Vascular Surgery Clinic, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess 6-month safety and efficacy of a self-expanding stent graft placement to treat stenotic or thrombosed synthetic arteriovenous access graft at the venous anastomoses. MATERIAL AND

methodsThis prospective, multicenter, post-market surveillance study assessed the GORE

resultsThe 103 enrolled patients (mean age 71.8 years; 57.3% female) had stent grafts placed in the venous anastomosis of arteriovenous access grafts (on-label). The majority of lesions were stenotic (77.1%) and located in the upper arm (91.4%). Mean lesion length was 42.9 ± 23.6 mm and diameter was 6.7 ± 1.9 mm; 28 patients (27.2%) had elephant trunk placements. Technical and clinical success rates were 100%. At 6 months, Kaplan-Meier estimates of target lesion and circuit PP were 75.1% (95% CI: 65.2, 82.6) and 66.8% (95% CI: 56.4, 75.3), and SP rates were 93.8% (95% CI: 86.7, 97.2) and 93.8% (95% CI: 86.7, 97.2), respectively. Mean cumulative number of reinterventions (0.36; 95% CI: 0.20, 0.51) and incidence of device- or procedure-related adverse events were low (⩽3%). No device deficiencies were reported.

conclusionsThe 6-month outcomes of the self-expanding stent graft to treat thrombosed venous anastomoses of synthetic hemodialysis vascular access grafts with stenosis demonstrated safety and effectiveness.

Indexed as

Arteriovenous Shunt, SurgicalBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationEndovascular ProceduresGraft Occlusion, VascularRenal DialysisThrombosisAgedAged, 80 and overFemaleHumansJapanMaleMiddle AgedProduct Surveillance, PostmarketingProspective Studiesarteriovenous accessArteriovenous graftGORE® VIABAHN® Endoprosthesishemodialysis vascular accessself-expanding stent graftvenous anastomoses

Identifiers

PMID39402727
PMCPMC12615843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.